Susquehanna Fundamental Investments’s CureVac CVAC Stock Holding History

Susquehanna Fundamental Investments’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-18,100	Closed	-$1.66M	–	1673
2021 Q1	$1.66M	Hold	18,100	–	–	0.03%	710
2020 Q4	$1.47M	Hold	18,100	–	–	0.03%	727
2020 Q3	$843K	Buy	+18,100	New	+$1.01M	0.03%	702

Other funds holding CVAC

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna Fundamental Investments's CVAC Position: Q2 2021 in Review

Susquehanna Fundamental Investments sold out of CureVac (CVAC) in Q2 2021, closing a stake of 18,100 shares — an estimated $1.66M sold.

Susquehanna Fundamental Investments first reported a position in CVAC in Q3 2020 and held it in 3 quarters. The position peaked at $1.66M in Q1 2021. 109 funds tracked by Wall St. Rank hold CVAC as of Q2 2021.

Susquehanna Fundamental Investments reported no remaining CureVac position as of Q2 2021 after selling out during the quarter.
Susquehanna Fundamental Investments sold 18,100 CureVac shares in Q2 2021, an estimated $1.66M.
Susquehanna Fundamental Investments first reported a position in CureVac in Q3 2020 and held it in 3 quarters.
Susquehanna Fundamental Investments's CureVac position peaked at $1.66M in Q1 2021.
109 funds tracked by Wall St. Rank held CureVac as of Q2 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2021, filed 11 Aug 2021.